BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15040699)

  • 1. [The treatment of leprosy in 2003].
    Flageul B
    Acta Leprol; 2003; 12(3):105-6. PubMed ID: 15040699
    [No Abstract]   [Full Text] [Related]  

  • 2. [How should leprosy be treated?].
    Mahé A
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of MDT on leprosy as measured by selective indicators.
    Jesudasan K; Vijayakumaran P; Pannikar VK; Christian M
    Lepr Rev; 1988 Sep; 59(3):215-23. PubMed ID: 3264374
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leprosy - An overview from a pediatric perspective].
    Magdorf K; Haas WH; Harms D; Höger PH; Griese M; Rank M
    Klin Padiatr; 2001; 213(5):266-70. PubMed ID: 11582524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin patches heralding relapse in a treated case of neuritic leprosy.
    Singh G; Dash K; Grover S; Sangolli P
    Lepr Rev; 1998 Dec; 69(4):400-1. PubMed ID: 9927814
    [No Abstract]   [Full Text] [Related]  

  • 6. Occurrence and management of leprosy reaction in China in 2005.
    Shen J; Liu M; Zhou M; Wengzhong L
    Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoimmunotherapy: its relevance in contemporary context.
    Sehgal VN; Jain S
    Int J Dermatol; 1994 Oct; 33(10):753-4. PubMed ID: 8002151
    [No Abstract]   [Full Text] [Related]  

  • 8. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
    Ganapati R; Pai VV; Shroff HJ; Gandewar K
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
    [No Abstract]   [Full Text] [Related]  

  • 9. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suspected leprosy].
    Velázquez de Castro y Sagarra A; López Bueno R; Gómez Jiménez G
    Aten Primaria; 1997 Jun; 20(2):107-8. PubMed ID: 9296648
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of oral zinc supplementation on the cell mediated immunity in lepromatous leprosy.
    el-Shafei MM; Kamal AA; Soliman H; el Shayeb F; Abdel Baqui MS; Faragalla S; Sabry MK
    J Egypt Public Health Assoc; 1988; 63(5-6):311-36. PubMed ID: 2979949
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of lepromatous leprosy with multiple relapses.
    Hulmani M; Marne RB; Dandakeri S
    Lepr Rev; 2009 Jun; 80(2):210-4. PubMed ID: 19743626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paucibacillary treatment for large tuberculoid lesions of leprosy?
    Santos MN; de Ferreira LC; Talhari S
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):225-7; author reply 227-8. PubMed ID: 16830649
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of fixed duration therapy.
    Mathew D; Kishore BN; Shwethadri GK; Sukumar ; Shetty NJ
    Indian J Lepr; 2004; 76(1):11-8. PubMed ID: 15527055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low.
    Gelber RH; Balagon VF; Cellona RV
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):493-500. PubMed ID: 15755209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent lepromatous leprosy in conventional triple therapy: value of the rifampicin-ofloxacin combination].
    Marlier S; Carsuzaa F; De Jaureguiberry JP; Galzin M; Carloz E; Carli P; Chagnon A
    Med Trop (Mars); 1995; 55(2):182. PubMed ID: 7565004
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bigger may not always be better: giant borderline tuberculoid leprosy lesion.
    Ghorpade A
    Lepr Rev; 2005 Jun; 76(2):182-3. PubMed ID: 16038255
    [No Abstract]   [Full Text] [Related]  

  • 19. Future trends in the treatment of leprosy.
    Pattyn SR
    Trop Geogr Med; 1994; 46(2):85-8. PubMed ID: 8079396
    [No Abstract]   [Full Text] [Related]  

  • 20. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.